Considerations for Insulin-Treated Type 2 Diabetes Patients During Hospitalization: A Narrative Review of What We Need to Know in the Age of Second-Generation Basal Insulin Analogs

With the availability of second-generation basal insulin analogs, insulin degludec (100 and 200 units/ml [degludec]) and insulin glargine 300 units/ml (glargine U300), clinicians now have long-acting, efficacious treatment options with stable pharmacokinetic profiles and associated low risks of hypo...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Souza, Sherwin C., Kruger, Davida F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526709/
https://www.ncbi.nlm.nih.gov/pubmed/33000382
http://dx.doi.org/10.1007/s13300-020-00920-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526709/
https://www.ncbi.nlm.nih.gov/pubmed/33000382
http://dx.doi.org/10.1007/s13300-020-00920-z

Ejemplares similares